48 PhD programmes in Biotechnology in Europe

The Plant Biology and Biotechnology programme offered by Universitat Autònoma de Barcelona develops advanced research expertise in plant systems, genetics, and biotechnological applications in agriculture and industry.

The Biotechnology programme offered by Universitat Autònoma de Barcelona develops advanced research expertise in biological systems, bioprocesses, and their applications in health, industry, and sustainability.

Plant Biosystems Design is jointly administered by the Universities of Bristol, University of Cambridge and York, and the John Innes Centre. It aims to catalyse interdisciplinary partnerships and drive innovation in the application of engineering principles to plant biology and biotechnology.

The Biotechnology programme offered by Lund University develops advanced research expertise in using microorganisms and biological systems for sustainable technological applications.

The Oenology and Biotechnology course from Rovira i Virgili University aims to train the students to carry out high-quality research in the fields of Oenology and Biotechnology.

The Biotechnology from University of Cambridge, offers a PhD in Biotechnology. The specifics of any project will dictate the activities of the student.  This can be molecular biology on through quantum mechanics. 

Biotechnology from Catholic University of Portugal aims to prepare a new generation of professionals, capable of promoting R&D activities, both at academic, research, and industry environments.

The PhD program in Life Sciences and Biotechnology at University of Ferrara is committed to educating scholars who will lead highly qualified experts in a broad field of animal and plant life sciences.

The Agricultural Sciences and Biotechnology programme offered by University of Udine develops expertise in crop improvement, livestock systems, and biological innovation.

The University School for Advanced Studies Pavia (IUSS) proudly presents the Biomolecular Sciences and Biotechnology doctoral program.

Research of the Doctoral School Biomaterials and Biointerfaces at University of Natural Resources and Life Sciences, Vienna focuses on the interaction between engineered materials and biological structures or tissues when they come into close contact.

The Doctoral Program in Biotechnology and Bioengineering (EDBB) at the Swiss Federal Institute of Technology in Lausanne provides doctoral students with the education necessary to be leaders in the fast-growing industrial and academic biotechnology and bioengineering sectors.

The Regenerative Sciences program at Hannover Medical School was developed as part of the Cluster of Excellence REBIRTH – ‘From Regenerative Biology to Reconstructive Therapy’. 

The research at the Pharmacy and Molecular Biotechnology program from Heidelberg University integrates experimental approaches of chemistry, molecular and cellular biology, pharmacology, bioinformatics, and pharmaceutics. 

Our Biochemistry and Biotechnology research at University of Glasgow aims to answer fundamental questions about how cells and organisms work at the molecular and biochemical level. 

The School at University College Dublin boasts a large cohort of graduate students enrolled in high quality structured M.Sc. (by research) and Ph.D. Biotechnology programmes that provide training in specific, state-of-the-art and generic research skills. 

The Stem Cell Biology Institute course from the University of Cambridge is a world-leading centre for stem cell research. Its mission is to transform human health through a deep understanding of stem cell biology.

The CLIB-Graduate Cluster Industrial Biotechnology is a joint initiative of three German universities: Heinrich Heine University Düsseldorf, Bielefeld University and TU Dortmund University.

The state North Rhine-Westphalia together with Bielefeld University, Dortmund University and Düsseldorf University funded a PhD program in Industrial Biotechnology, the CLIB graduate cluster.

The Biochemical Engineering programme at University College London (UCL) trains the bioprocess engineering leaders of the future who will underpin the translation of new scientific advances into safe, selective and manufacturable therapies for often currently intractable conditions, but at affordable costs.